These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19211723)

  • 21. Addition of a low dose of rimonabant to orlistat therapy decreases weight gain and reduces adiposity in dietary obese rats.
    Zaitone SA; Essawy S
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):551-9. PubMed ID: 22524969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice.
    Wu R; Sun JG; Wang JQ; Li B; Liu Q; Ning G; Jin W; Yuan Z
    Diabetologia; 2017 May; 60(5):900-910. PubMed ID: 28074253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs.
    Richey JM; Woolcott OO; Stefanovski D; Harrison LN; Zheng D; Lottati M; Hsu IR; Kim SP; Kabir M; Catalano KJ; Chiu JD; Ionut V; Kolka C; Mooradian V; Bergman RN
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1311-8. PubMed ID: 19366874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of Chlorella on glucose and lipid metabolism in obese rodents on a high-fat diet.
    Noguchi N; Konishi F; Kumamoto S; Maruyama I; Ando Y; Yanagita T
    Obes Res Clin Pract; 2013; 7(2):e95-e105. PubMed ID: 24331771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fish oil prevents changes induced by a high-fat diet on metabolism and adipokine secretion in mice subcutaneous and visceral adipocytes.
    de Sá RD; Crisma AR; Cruz MM; Martins AR; Masi LN; do Amaral CL; Curi R; Alonso-Vale MI
    J Physiol; 2016 Nov; 594(21):6301-6317. PubMed ID: 27558442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
    McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW; Kilp S; Elvert R; Haschke G; Kramer W
    Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant.
    Maynadier M; Basile I; Gary-Bobo M
    Drug Discov Today; 2009 Feb; 14(3-4):192-7. PubMed ID: 18951999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.
    Lim SY; Davidson SM; Yellon DM; Smith CC
    Basic Res Cardiol; 2009 Nov; 104(6):781-92. PubMed ID: 19462153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice.
    Chen B; Hu N
    Braz J Med Biol Res; 2017 May; 50(6):e6141. PubMed ID: 28492810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
    Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
    Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys.
    Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.
    Bajzer M; Olivieri M; Haas MK; Pfluger PT; Magrisso IJ; Foster MT; Tschöp MH; Krawczewski-Carhuatanta KA; Cota D; Obici S
    Diabetologia; 2011 Dec; 54(12):3121-31. PubMed ID: 21987346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice.
    Jourdan T; Djaouti L; Demizieux L; Gresti J; Vergès B; Degrace P
    Diabetes; 2010 Apr; 59(4):926-34. PubMed ID: 20110567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.